Clinical Significance of Composition and Functional Diversity of the Vaginal Microbiome in Recurrent VaginitisOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
Researchers compared the vaginal microbiome taxonomic profile of 40 Korean women with recurrent vaginitis (RV) to 100 healthy women of reproductive age. They also examined how community state type (CST) related to clinical features, including underlying uterine disease.
How was it studied?
Vaginal samples were analyzed using 16S ribosomal RNA gene sequencing. Species abundance, evenness, diversity, and beta diversity were compared between RV patients and healthy controls, and CST categories were assigned to each RV sample.
What did they find?
Species abundance was significantly lower in RV patients, while species evenness and diversity were significantly higher, compared to healthy women (p < 0.05). Lactobacillus spp. proportion was significantly lower in RV patients (p < 0.01), and beta diversity differed significantly between groups (p = 0.001). Most RV samples fell into CST IV (52.5%), followed by CST III (20.0%), CST I (12.5%), CST II (5.0%), CST V (2.5%), and mixed CST (7.5%). Patients with underlying uterine disease (leiomyoma, adenomyosis, or endometrial polyps; n = 17) had higher species richness and diversity than those without (n = 23, p < 0.05).
Why it matters
The findings tie reduced Lactobacillus dominance and altered diversity to recurrent vaginitis, and link greater microbial diversity to co-occurring gynecologic disease. The authors propose vaginal microbiome surveillance as a tool for detecting and managing gynecologic conditions.